Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis

BACKGROUND: Gastric cancer (GC) is a strong cause of global cancer mortality. Nucleotide excision repair (NER) can modulate platinum-based chemotherapeutic efficacy by removing drug-produced DNA damage. Some studies have found a link between excision repair cross complementation group 1 (ERCC1) rs22...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yalei, Xu, Mengyuan, Sun, Yidan, Liu, Yezhou, Zhao, Lijuan, Liu, Xuehui, Li, Zixuan, Shi, Gaiping, Jia, Jinhai, Bi, Lanfei, Ma, Ning, Zhang, Xiaolin, Qi, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376342/
https://www.ncbi.nlm.nih.gov/pubmed/34414935
http://dx.doi.org/10.1097/MD.0000000000026850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376342/
https://www.ncbi.nlm.nih.gov/pubmed/34414935
http://dx.doi.org/10.1097/MD.0000000000026850

Ejemplares similares